Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG in Endoscopic Resection of Non-functioning Pituitary Macroadenomas
NCT07763236Completed
- Start
- Feb 2019
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
Randomised, single-blind trial of indocyanine green in non-functioning pituitary adenoma (NFPA) (2 arms). Primary endpoint: Complete tumor resection. Started Feb 2019; status: completed.
02
Drugs
indocyanine green
03
Conditions
non-functioning pituitary adenoma (NFPA)
Beyond the preview
Go deeper on NCT07763236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07763236.